Northern Trust’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Hold |
11,387
| – | – | ﹤0.01% | 4332 |
|
|
2025
Q1 | $15.5K | Hold |
11,387
| – | – | ﹤0.01% | 4363 |
|
|
2024
Q4 | $43.2K | Buy |
+11,387
| New | +$43.2K | ﹤0.01% | 4281 |
|
|
2024
Q1 | – | Sell |
-4,448
| Closed | -$30.6K | – | 4471 |
|
|
2023
Q4 | $30.6K | Hold |
4,448
| – | – | ﹤0.01% | 4317 |
|
|
2023
Q3 | $28K | Hold |
4,448
| – | – | ﹤0.01% | 4272 |
|
|
2023
Q2 | $36.9K | Hold |
4,448
| – | – | ﹤0.01% | 4287 |
|
|
2023
Q1 | $19.6K | Hold |
4,448
| – | – | ﹤0.01% | 4453 |
|
|
2022
Q4 | $26.2K | Hold |
4,448
| – | – | ﹤0.01% | 4427 |
|
|
2022
Q3 | $31K | Hold |
4,448
| – | – | ﹤0.01% | 4451 |
|
|
2022
Q2 | $64K | Hold |
4,448
| – | – | ﹤0.01% | 4333 |
|
|
2022
Q1 | $167K | Hold |
4,448
| – | – | ﹤0.01% | 4193 |
|
|
2021
Q4 | $347K | Buy |
+4,448
| New | +$347K | ﹤0.01% | 3949 |
|